Results 51 to 60 of about 124,351 (162)

Investigation of biofilm production and hemolytic activity in various Candida isolates

open access: yesMedicine Science
In this study, it was aimed to investigate and compare biofilm production and hemolytic activity in various Candida isolates obtained from different clinical specimens. A total of 100 clinical isolates, 53 C. albicans and 47 non albicans Candida strains,
Merih Simsek, Cengiz Demir
doaj   +1 more source

Effect of Piper betle and Brucea javanica on the Differential Expression of Hyphal Wall Protein (HWP1) in Non-Candida albicans Candida (NCAC) Species [PDF]

open access: yes, 2014
The study aimed to identify the HWP1 gene in non-Candida albicans Candida species and the differential expression of HWP1 following treatment with Piper betle and Brucea javanica aqueous extracts.
Jamil, N. A.   +3 more
core   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina

open access: yes, 2018
Fil: Taverna, Constanza Giselle. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Micología; Argentina.Fil: Córdoba, Susana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas.
Graciela Davel   +13 more
core   +1 more source

Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre

open access: yesMycoses, Volume 68, Issue 12, December 2025.
ABSTRACT Background Recent literature indicates a decline in rates of candidemia in the general population. Objectives To analyse temporal trends in candidemia among patients with solid tumours and haematological malignancies admitted to a dedicated cancer centre.
Mohammad El‐Atoum   +4 more
wiley   +1 more source

Candida guilliermondiiおよびCandida fermentatiの臨床的・微生物学的特徴 [PDF]

open access: yes, 2018
A total of 46 clinical isolates of Candida guilliermondii and Candida famata were reidentified genetically, resulting in 27 C. guilliermondii and 12 Candida fermentati strains. The majority of C. guilliermondii strains, but not C.
平山, 達朗
core   +2 more sources

Candida famata (Debaryomyces hansenii) DNA sequences containing genes involved in riboflavin synthesis

open access: yes, 2004
famata RIB genes have been submitted to the EMBL data library under Accession Nos AJ810169-AJ810173.International audiencePreviously cloned Candida famata (Debaryomyces hansenii) strain VKM Y-9 genomic DNA fragments containing genes RIB1 (codes for GTP ...
Abbas, C.A.   +7 more
core   +1 more source

Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre

open access: yesBMC Infectious Diseases, 2018
Background In recent years, there has been a significant increase in the incidence of fungal infections attributed to Candida species worldwide, with a major shift toward non-albicans Candida (NAC).
Lyn Awad   +9 more
doaj   +1 more source

De novo sequence assembly of Albugo candida reveals a small genome relative to other biotrophic oomycetes [PDF]

open access: yes, 2011
Background: Albugo candida is a biotrophic oomycete that parasitizes various species of Brassicaceae, causing a disease (white blister rust) with remarkable convergence in behaviour to unrelated rusts of basidiomycete fungi.
Beynon, E.   +39 more
core   +2 more sources

Production of the Antimicrobial Roseoflavin With Genetically Engineered Corynebacterium glutamicum

open access: yesMicrobial Biotechnology, Volume 18, Issue 10, October 2025.
Corynebacterium glutamicum was genetically engineered for the production of the riboflavin analog roseoflavin, while minimising its antimicrobial effects. To this end, the genetic machinery from the natural roseoflavin producer Streptomyces davaonensis was evaluated in a riboflavin‐producing C. glutamicum strain.
Luciana Fernandes Brito   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy